Associate Director, Payer Value and Outcomes

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit and follow @JazzPharma on Twitter. Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients'' lives by identifying, developing and commercializing meaningful products that address unmet medical needs. We are continuing to expand our commercial product portfolio and research and development pipeline in therapeutic areas that can leverage our unique expertise.Our therapeutic areas of focus include neuroscience (epilepsy, movement disorders and sleep) and hematology/oncology - areas in which we have a deep understanding of the patient journey and a suite of products and product candidates to address critical needs.The Associate Director, Payer, Value & Outcomes (PVO) serves as the field-based scientific lead for medical payer engagement strategy across therapeutic areas for Jazz marketed and pipeline products and is the medical point of contact for key US payers. As payers continue to shift from population-base to patient-centered formulary management, special evidentiary requirements, including real-world evidence (RWE) and health care economic information (HCEI) become increasingly important to the medication coverage decision-making process. The Associate Director, PVO support payers sophisticated evidence needs with research and scientific exchange of data, including real-world evidence (RWE) and HCEI in alignment with the 21st Century Cure''s Act to inform evidence-based formulary, utilization and access decisions on Jazz products and in relevant therapeutic areas. The Associate Director understands key scientific questions, identifies evidence gaps, provide customer insights that inform medical and value evidence generation plans and collaborates to generate research. The Associate Director, PVO works closely with other medical colleagues and cross-functional partners (Global Health Economics & Outcomes Research (GHEOR), Real World Evidence (RWE), MedComm, Market Access, etc.) to demonstrate the value proposition for Jazz'' products, technologies and services in support of optimal patient care.Essential FunctionsServe as the first-line Jazz medical point of contact for clinical, health outcomes, and real-world evidence, and provide support across therapeutic areas to key national formulary decision-makers in a manner consistent with Jazz'' principles for scientific engagement. Develop Scientific Account Plans with strategic tactics for key accounts that demonstrate a deep understanding of payer''s population-management strategies, scientific priorities, evidence needs, decision-making processes, and clinical perspectives on Jazz products.Build relationships and establish scientific and professional credibility within national managed care organizations, health care systems, government payers, and with other stakeholders involved in formulary management, medication positioning, value discussions and health care policy. Engage in credible and transparent scientific information exchange that resonates with payers when responding to unsolicited requests for clinical, health outcomes and pharmacoeconomic information and proactively communicates HCEI in alignment with the 21st Century Cure''s Act.Provide customer insights to internal teams on key evidence gaps relevant to health care decision makers to guide GHEOR, RWE and Clinical team''s strategic development of impactful value evidence generation and clinical development plans for marketed and pipeline products.Facilitate educational and collaborative research opportunities, and partner with GHEOR and RWE to conduct and publish HEOR and HCEI in alignment with Jazz'' standard operating procedures (SOPs).Collaborate with cross-functional partners on the development of educational tools and resources (disease state education, payer-focused slide decks, Medicaid testimony, economic models, etc.) communicated to customers to improve relevant therapeutic area understanding and access to Jazz'' marketed and pipeline products.Implement and execute scientific training for the PVO team and cross-functional partners (ARM, Field Payer/Market Access teams and HEOR).Collaborate with the Medical Affairs trainer and Medical Science Liaison (MSL) management to provide managed markets training and mentorship for MSLs.Collaborate and build strong relationships with cross-functional partners and internal stakeholders and ensure continuous and consistent communication on activities/projects.Represent PVO as the technical/medical payer expert on cross-functional internal teams.Ensure compliance with all applicable laws, regulations and regulatory guidelines governing commercial and scientific interactions with healthcare professionals, payers, advocacy and other business partners.Required Knowledge, Skills, and Abilities Minimum of 5 years of post-doctoral relevant scientific work experience in a pharmaceutical industry or managed markets setting (Managed Care/PBM, VA/DoD, CMS, State Medicaid, etc.), payer strategy, clinical practice, outcomes and/or related disciplines, with 2 of these years in a field-based payer/outcomes roleDemonstrated proficiency in managing and maintaining knowledge in multiple therapeutic areas (neurology, hematology and oncology is strongly preferred) and strategic initiatives including health outcomes, quality initiatives, consensus standards, evidence-based guidelines and health care policyIn-depth knowledge of the biopharmaceutical industry and US managed markets, including various access and reimbursement models (Managed Care, Medicare Part B, Part D and Medicaid, etc.)Demonstrated expertise in health outcomes, health care policy, health technology assessment, and pharmacoeconomic principles including AMCP Dossiers, 21st Century Cures Act, Institute for Clinical and Economic Review (ICER) and pharmacoeconomic models and their application to evaluate and deliver the value of medicinesExcellent analytical, written, and verbal communication and experience presenting critical medical, health economic data and business information to internal stakeholders and external national payer customersStrong strategic-thinking skills; demonstrated ability to network and identify opportunities for medical engagement, set scientific engagement goals, and create and influence value propositions for innovative medicines and servicesStrong personal integrity, interpersonal skills, teamwork abilities and customer focus.Demonstrated ability to organize, adapt, prioritize, and work effectively in a matrixed organization and in an evolving/changing health care environment.Ability to travel approximately 50-60% timeRequired/Preferred Education and LicensesAdvanced degree in the health sciences (MD, PharmD, PhD) is required. An additional master''s degree in business or health economics is preferred (e.g. MBA, MS)Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.

Created: 2025-11-15